Allogeneic Stem Cell Transplantation
Allogeneic transplantation has dramatically grown in importance as a curative cellular therapy for patients with hematologic malignancies and selected solid tumors, marrow failure disorders, and inherited metabolic diseases. In Allogeneic Stem Cell Transplantation: Clinical Research and Practice, in...
Other Authors: | , |
---|---|
Format: | eBook |
Language: | English |
Published: |
Totowa, NJ
Humana
2003, 2003
|
Edition: | 1st ed. 2003 |
Series: | Current Clinical Oncology
|
Subjects: | |
Online Access: | |
Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- 1 Hematopoietic Stem Cell Transplantation: A Historical Perspective
- 2 Allogeneic Hematopoietic Cell Transplantation for Adult Patients with Acute Myelogenous Leukemia
- 3 Allogeneic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia
- 4 Chronic Myelogenous Leukemia
- 5 Allogeneic Stem Cell Transplantation for Breast Cancer
- 6 Allogeneic Transplantation for the Treatment of Multiple Myeloma
- 7 Non-Hodgkin’s Lymphoma
- 8 Blood vs Marrow Allogeneic Stem Cell Transplantation
- 9 Haploidentical Stem Cell Transplantation
- 10 Umbilical Cord Blood Transplantation
- 11 Mesenchymal Stem Cells in Allogeneic Transplantation
- 12 Cytokines in Allogeneic Stem Cell Mobilization
- 13 Nonmyeloablative Allogeneic Transplantation
- 14 Recent Developments in Epidemiology and Management of Invasive Fungal Infections
- 15 Immune Recovery Following Allogeneic Blood Transplantation: Mechanisms of Immune Dysfunction
- 16 Grading and Management of Graft-vs-Host Disease
- 17 Posttransplant EBV-Associated Disease
- 18 Allogeneic Antitumor Vaccine Strategies
- 19 Donor Leukocyte Infusions
- 20 Second Hematopoietic Stem Cell Transplantation for the Treatment of Graft Failure, Graft Rejection, or Relapse
- 21 The Role of T Cell Depletion in Bone Marrow Transplantation
- 22 Minimal Residual Disease in Allogeneic Recipients
- 23 Nonhuman Primate Models of Hematopoietic Stem Cell Transplantation
- 24 In Vivo Models for the Study of Graft-vs-Host Disease and Graft-vs-Tumor Effects
- 25 Allogeneic Effector Cell Populations: Separating GVL from GVHD
- 26 Dendritic Cells: Immunobiology and Potential Use for Cancer Immunotherapy
- 27 Epilogue